# Grace Therapeutics, Inc.: Form 8-K, filed Apr 20, 2020

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2020-04-20
- Accepted by EDGAR: Apr 20, 2020, 16:05 ET
- Period: 2020-04-17
- Accession: 0001171843-20-002717
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000117184320002717/f8k_042020.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000117184320002717/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000117184320002717/f8k_042020.htm

Filed Apr 20, 2020.
Source: SEC EDGAR, the filing index for accession 0001171843-20-002717. Last ingested by Listed: Nov 14, 2026, 23:10 ET. No prices; not investment advice.
